SuperworthAdma Biologics shares outstanding ADMA
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 230.3M
- On a year earlier
- −7.3%
- fewer shares
Adma Biologics had 230.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 7.3% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 243.2M | −2% |
| FY2024 | 248M | +10% |
| FY2023 | 226M | +11% |
| FY2022 | 202.8M | +12% |
| FY2021 | 180.8M | +87% |
| FY2020 | 96.6M | +63% |
| FY2019 | 59.3M | +28% |
| FY2018 | 46.4M | +28% |
| FY2017 | 36.2M | +181% |
| FY2016 | 12.9M | +24% |
| FY2015 | 10.4M | +12% |
| FY2014 | 9.3M | +9% |
| FY2013 | 8.5M | +45% |
| FY2012 | 5.9M | +135% |
| FY2011 | 2.5M | +0% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 230.3M | −7% | |
| Q1 FY26 | 240M | −2% | |
| Q4 FY25 | 243.2M | −2% | |
| Q3 FY25 | 244.7M | −0% | |
| Q2 FY25 | 248.6M | +3% | |
| Q1 FY25 | 244.7M | +3% | |
| Q4 FY24 | 248M | +10% | |
| Q3 FY24 | 244.8M | +5% | |
| Q2 FY24 | 242.2M | +9% | |
| Q1 FY24 | 236.4M | +7% | |
| Q4 FY23 | 226M | +11% | |
| Q3 FY23 | 233.8M | +19% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Adma Biologics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.